Related Experiment Videos

[The assessment of therapeutic success in chronic myeloid leukemia]

M Griesshammer¹, R Hehlmann, H Heimpel

¹Abteilung Innere Medizin III, Universität Heidelberg.

Deutsche Medizinische Wochenschrift (1946)

|April 28, 1995

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Randomized phase-II trial evaluating induction therapy with idarubicin and etoposide plus sequential or concurrent azacitidine and maintenance therapy with azacitidine.

Leukemia·2019

Splanchnic vein thrombosis in myeloproliferative neoplasms: risk factors for recurrences in a cohort of 181 patients.

Blood cancer journal·2016

CD44 as a Potential Screening Marker for Preliminary Differentiation Between Congenital Dyserythropoietic Anemia Type II and Hereditary Spherocytosis.

Cytometry. Part B, Clinical cytometry·2016

Pomalidomide in myeloproliferative neoplasm-associated myelofibrosis.

Leukemia·2016

Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendations.

Leukemia·2016

High rate of recurrent venous thromboembolism in patients with myeloproliferative neoplasms and effect of prophylaxis with vitamin K antagonists.

Leukemia·2016

See all related articles